Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 10/20 | 0.68 |
| ▸ | CA9 | Q16790 | 10/20 | 0.68 |
| ▸ | CA1 | P00915 | 9/20 | 0.68 |
| ▸ | CA6 | P23280 | 5/20 | 0.68 |
| ▸ | CA7 | P43166 | 5/20 | 0.68 |
| ▸ | CA14 | Q9ULX7 | 5/20 | 0.68 |
| ▸ | CA4 | P22748 | 5/20 | 0.68 |
| ▸ | CA5B | Q9Y2D0 | 3/20 | 0.68 |
| ▸ | CA2 | P00918 | 3/20 | 0.68 |
| ▸ | CA5A | P35218 | 3/20 | 0.68 |
| ▸ | CA3 | P07451 | 3/20 | 0.68 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.63 |
| ▸ | MAOB | P27338 | 7/20 | 0.62 |
| ▸ | MAOA | P21397 | 6/20 | 0.62 |
| ▸ | MTNR1A | P48039 | 3/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.58 |
| ▸ | NPC1 | O15118 | 2/20 | 0.57 |
| ▸ | MEN1 | O00255 | 1/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12304245 | 0.87 | CA12 (0.81) | CA12CA9CA1CA6CA7 | |
| SCHEMBL5662843 | 0.87 | CA12 (0.74) | CA12CA9CA1CA6CA7 | |
| SCHEMBL4390495 | 0.84 | CA12 (0.75) | CA12CA9CA1CA6CA7 | |
| SCHEMBL24045405 | 0.84 | CA12 (0.82) | CA12CA9CA1CA6CA7 | |
| SCHEMBL20005597 | 0.81 | CA12 (0.72) | CA12CA9CA1CA6CA7 | |
| SCHEMBL9214643 | 0.81 | CA12 (0.77) | CA12CA9CA1CA6CA7 | |
| SCHEMBL6590585 | 0.81 | CA12 (0.72) | CA12CA9CA1CA6CA7 | |
| SCHEMBL8515810 | 0.81 | CA12 (1.00) | CA12CA9CA1CA6CA7 | |
| SCHEMBL31086804 | 0.81 | CA12 (0.77) | CA12CA9CA1CA6CA7 | |
| SCHEMBL6834561 | 0.81 | CA12 (1.00) | CA12CA9CA1CA6CA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1285086-B1 | METHOD FOR LIBERATING A PRODUCT COMPRISING A CHEMICAL OXYDATION, DETECTION OF THE PRODUCT AND FURTHER APPLICATIONS | PROTEUS (FR) | 2013-07-03 | — | — | EP | disclosed |
| US-20070231820-A1 | P450 ENZYMES, NUCLEIC ACIDS ENCODING THEM AND METHODS OF MAKING AND USING THEM | DIVERSA CORPORATION (US) | 2007-10-04 | — | — | US | disclosed |
| US-7258972-B2 | Process for generating the idiosyncratic catalytic imprint of a sample, the processing of said imprint and the systems for implementation thereof | PROTEUS (FR) | 2007-08-21 | — | — | US | disclosed |
| US-7232672-B2 | P450 enzymes, nucleic acids encoding them and methods of making and using them | DIVERSA CORPORATION (US) | 2007-06-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070231820-A1 | P450 ENZYMES, NUCLEIC ACIDS ENCODING THEM AND METHODS OF MAKING AND USING THEM | CYP2F1, CYP21A2, CYP2E1 | CA12 2416/4885CA9 1939/4885CA1 2139/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.